ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Biohaven Ltd

Biohaven Ltd (BHVN)

37,48
0,76
(2,07%)
Geschlossen 14 Januar 10:00PM
37,48
0,00
(0,00%)
Nach Börsenschluss: 11:30PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
37,48
Gebot
-
Fragen
-
Volumen
1.089.666
34,20 Tagesbereich 37,61
26,80 52-Wochen-Bereich 62,21
Marktkapitalisierung
Handelsende
36,72
Handelsbeginn
37,21
Letzte Trade
107968
@
37.48
Letzter Handelszeitpunkt
Finanzvolumen
US$ 39.354.560
VWAP
36,1162
Durchschnittliches Volumen (3 Mio.)
911.490
Ausgegebene Aktien
101.122.246
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-9,31
Gewinn pro Aktie (EPS)
-4,04
Erlöse
-
Nettogewinn
-408,17M

Über Biohaven Ltd

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Road Town, Tortola, Vgb
Gegründet
-
Biohaven Ltd is listed in the Pharmaceutical Preparations sector of the New York Börse with ticker BHVN. The last closing price for Biohaven was US$36,72. Over the last year, Biohaven shares have traded in a share price range of US$ 26,80 to US$ 62,21.

Biohaven currently has 101.122.246 shares in issue. The market capitalisation of Biohaven is US$3,71 billion. Biohaven has a price to earnings ratio (PE ratio) of -9.31.

Option-Flow Biohaven (BHVN)

Gesamtfluss

Bullisch

Nettoprämie

172k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

BHVN Neueste Nachrichten

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Po

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective...

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs

NEW HAVEN, Conn. and UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Biohaven Ltd. (NYSE: BHVN) and Merus N.V. (Nasdaq:MRUS), today announced a research...

Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire NEW HAVEN, Conn., Jan. 7, 2025 NEW HAVEN, Conn., Jan. 7, 2025 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) today...

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other...

Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting

Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual...

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity PR Newswire NEW HAVEN, Conn., Nov. 25, 2024 In the RESILIENT SMA study, taldefgrobep...

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments PR Newswire NEW HAVEN, Conn., Nov. 12, 2024 Cash, cash equivalents, marketable securities and restricted...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.2775-3.296136231738.757540.456535.08115220138.30167384CS
40.1050.28093645484937.37542.1334.46124064037.49074311CS
12-14.76-28.254211332352.2454.9834.4691149043.27210691CS
26-1.04-2.6998961578438.5255.3932.8395402743.11451276CS
52-7.02-15.775280898944.562.2126.8111545443.44918272CS
156-86.11-69.6739218383123.59152.567.1116089553.93157613CS
260-19.17-33.83936451956.65152.567.196182860.60258561CS

BHVN - Frequently Asked Questions (FAQ)

What is the current Biohaven share price?
The current share price of Biohaven is US$ 37,48
How many Biohaven shares are in issue?
Biohaven has 101.122.246 shares in issue
What is the market cap of Biohaven?
The market capitalisation of Biohaven is USD 3,71B
What is the 1 year trading range for Biohaven share price?
Biohaven has traded in the range of US$ 26,80 to US$ 62,21 during the past year
What is the PE ratio of Biohaven?
The price to earnings ratio of Biohaven is -9,31
What is the reporting currency for Biohaven?
Biohaven reports financial results in USD
What is the latest annual profit for Biohaven?
The latest annual profit of Biohaven is USD -408,17M
What is the registered address of Biohaven?
The registered address for Biohaven is P.O. BOX 173, ROAD TOWN, TORTOLA
What is the Biohaven website address?
The website address for Biohaven is www.biohavenpharma.com
Which industry sector does Biohaven operate in?
Biohaven operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
LXULSB Industries Inc
US$ 9,095
(22,24%)
960,77k
NVRONevro Corp
US$ 4,02
(22,19%)
1,53M
AMWLAmerican Well Corporation
US$ 8,60
(19,11%)
144,11k
AGLAgilon Health inc
US$ 2,885
(18,72%)
7,79M
PDXPIMCO Dynamic Income Strategy Fund
US$ 30,23
(17,44%)
3,94M
QBTSD Wave Quantum Inc
US$ 3,82
(-33,80%)
107,29M
SESSES AI Corporation
US$ 0,94
(-25,98%)
21,68M
ALURAllurion Technologies Inc
US$ 2,90
(-24,08%)
189,33k
STEMStem Inc
US$ 0,6735
(-17,94%)
20,85M
ENFYEnlightify Inc
US$ 0,8518
(-17,10%)
48,43k
QBTSD Wave Quantum Inc
US$ 3,82
(-33,80%)
107,29M
PCGPG&E Corporation
US$ 16,185
(-5,74%)
69,64M
FFord Motor Company
US$ 9,7058
(0,58%)
66,02M
FUBOfuboTV
US$ 4,445
(-13,01%)
59,47M
IONQIonQ Inc
US$ 27,86
(-13,83%)
52,77M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock